BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15143852)

  • 21. Neural autoantibodies and neurophysiologic abnormalities in patients exposed to molds in water-damaged buildings.
    Campbell AW; Thrasher JD; Madison RA; Vojdani A; Gray MR; Johnson A
    Arch Environ Health; 2003 Aug; 58(8):464-74. PubMed ID: 15259425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of multi-contaminant exposure in a cancer treatment center: a 2-year monitoring of molds, mycotoxins, endotoxins, and glucans in bioaerosols.
    Heutte N; André V; Dubos Arvis C; Bouchart V; Lemarié F; Legendre P; Votier E; Louis MY; Madelaine S; Séguin V; Gente S; Vérité P; Garon D
    Environ Monit Assess; 2017 Jan; 189(1):31. PubMed ID: 28012082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indoor fungal diversity and asthma: a meta-analysis and systematic review of risk factors.
    Sharpe RA; Bearman N; Thornton CR; Husk K; Osborne NJ
    J Allergy Clin Immunol; 2015 Jan; 135(1):110-22. PubMed ID: 25159468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brainstem auditory evoked response in adolescents with acoustic mycotic neuroma due to environmental exposure to toxic molds.
    Anyanwu E; Campbell AW; High W
    Int J Adolesc Med Health; 2002; 14(1):67-76. PubMed ID: 12467209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between the prevalence of certain fungi and sick building syndrome.
    Cooley JD; Wong WC; Jumper CA; Straus DC
    Occup Environ Med; 1998 Sep; 55(9):579-84. PubMed ID: 9861178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Microbiological threat from buildings and rooms and its influence on human health (sick building syndrome)].
    Ochmański W; Barabasz W
    Przegl Lek; 2000; 57(7-8):419-23. PubMed ID: 11109318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can we use indoor fungi as bioindicators of indoor air quality? Historical perspectives and open questions.
    Cabral JP
    Sci Total Environ; 2010 Sep; 408(20):4285-95. PubMed ID: 20655574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The biocontaminants and complexity of damp indoor spaces: more than what meets the eyes.
    Thrasher JD; Crawley S
    Toxicol Ind Health; 2009; 25(9-10):583-615. PubMed ID: 19793773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An environmental assessment of mold concentrations and potential mycotoxin exposures in the greater Southeast Texas area.
    Khan NN; Wilson BL
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2003; 38(12):2759-72. PubMed ID: 14672314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of trichothecene mycotoxins in sera from individuals exposed to Stachybotrys chartarum in indoor environments.
    Brasel TL; Campbell AW; Demers RE; Ferguson BS; Fink J; Vojdani A; Wilson SC; Straus DC
    Arch Environ Health; 2004 Jun; 59(6):317-23. PubMed ID: 16238166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. JEM Spotlight: Fungi, mycotoxins and microbial volatile organic compounds in mouldy interiors from water-damaged buildings.
    Polizzi V; Delmulle B; Adams A; Moretti A; Susca A; Picco AM; Rosseel Y; Kindt R; Van Bocxlaer J; De Kimpe N; Van Peteghem C; De Saeger S
    J Environ Monit; 2009 Oct; 11(10):1849-58. PubMed ID: 19809708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sick building syndrome. III. Stachybotrys chartarum.
    Mahmoudi M; Gershwin ME
    J Asthma; 2000 Apr; 37(2):191-8. PubMed ID: 10805208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indoor air effects after building renovation and in manufactured homes.
    Kilburn KH
    Am J Med Sci; 2000 Oct; 320(4):249-54. PubMed ID: 11061350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health effects of mycotoxins in indoor air: a critical review.
    Robbins CA; Swenson LJ; Nealley ML; Gots RE; Kelman BJ
    Appl Occup Environ Hyg; 2000 Oct; 15(10):773-84. PubMed ID: 11036728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Saliva secretory IgA antibodies against molds and mycotoxins in patients exposed to toxigenic fungi.
    Vojdani A; Kashanian A; Vojdani E; Campbell AW
    Immunopharmacol Immunotoxicol; 2003 Nov; 25(4):595-614. PubMed ID: 14686801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycotoxins and antifungal drug interactions: implications in the treatment of illnesses due to indoor chronic toxigenic mold exposures.
    Anyanwu EC; Campbell AW; Ehiri JE
    ScientificWorldJournal; 2004 Mar; 4():167-77. PubMed ID: 15105956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moisture-problem buildings with molds causing work-related diseases.
    Reijula K
    Adv Appl Microbiol; 2004; 55():175-89. PubMed ID: 15350794
    [No Abstract]   [Full Text] [Related]  

  • 38. The characteristics of indoor and outdoor fungi and their relation with allergic respiratory diseases in the southern region of Turkey.
    Arikoglu T; Batmaz SB; Coşkun T; Otag F; Yildirim DD; Kuyucu S
    Environ Monit Assess; 2016 Jun; 188(6):380. PubMed ID: 27236446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of environmental factors on airborne fungi in houses of Santa Fe City, Argentina.
    Basilico Mde L; Chiericatti C; Aringoli EE; Althaus RL; Basilico JC
    Sci Total Environ; 2007 Apr; 376(1-3):143-50. PubMed ID: 17320936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Literature on mycotoxins and human health at the time of the ACOEM report.
    Hodgson MJ; Dearborn DG
    Int J Occup Environ Health; 2009; 15(1):115-7. PubMed ID: 19267132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.